Jpmorgan Chase & Company Stake In Pfizer INC (PFE) Was Increased

April 20, 2018 - By Ashley Edward

Pfizer Inc. (NYSE:PFE) Corporate LogoBig Money Sentiment increased to 1.06 in 2017 Q4. It has change of 0.10, from 2017Q3’s 0.96. The ratio improved due to PFE positioning: 51 sold and 675 reduced. 134 funds bought holdings and 632 increased holdings. Investors holded 4.06 billion in 2017Q3 but now own 4.07 billion shares or 0.28% more. Johnson Fincl Group Inc holds 0.6% of its capital in Pfizer Inc. (NYSE:PFE) for 136,097 shs. Stone Ridge Asset Management reported 0.4% in Pfizer Inc. (NYSE:PFE). Korea Inv has 4.66 million shs for 0.77% of their capital. Raymond James Na invested 1.25% in Pfizer Inc. (NYSE:PFE). Parametrica Management holds 0.16% in Pfizer Inc. (NYSE:PFE) or 6,953 shs. 178,170 were accumulated by Birmingham Cap Mngmt Al. Barnett & Com stated it has 0.03% of its capital in Pfizer Inc. (NYSE:PFE). Carret Asset Ltd Liability Corp holds 0.7% in Pfizer Inc. (NYSE:PFE) or 124,557 shs. Keybank Natl Association Oh owns 4.06 million shs or 0.84% of their US capital. Cortland Assoc Mo, a Missouri-based fund reported 13,561 shs. Numeric Investors Ltd Liability Com owns 307,400 shs or 0.08% of their US capital. Creative Planning reported 0.12% in Pfizer Inc. (NYSE:PFE). Brick & Kyle Assoc accumulated 11,136 shs. Private Asset Management Inc accumulated 494,822 shs. Riggs Asset Managment Com holds 0.03% in Pfizer Inc. (NYSE:PFE) or 2,349 shs.

PFE had 12 insider sales and 0 buys since December 15, 2017. This’s net activity of $12.99 million. On Saturday, February 24 LUND-JURGENSEN KIRSTEN sold $353,677 worth of Pfizer Inc. (NYSE:PFE) or 9,510 shs. On Friday, March 2 Dolsten Mikael sold $501,398 worth of Pfizer Inc. (NYSE:PFE) or 13,986 shs. 6,750 shs were sold by MACKENZIE ALEXANDER R, worth $249,750 on Friday, December 15. SUSMAN SALLY sold $1.24 million worth of stock or 33,368 shs. On Monday, February 26 Shares for $64,679 were sold by CORNWELL W DON. On Tuesday, March 13 27,323 shs were sold by JOHNSON RADY A, worth $998,666.

Jpmorgan Chase & Company’s holdings in Pfizer Inc (PFE) is increased by 1.29% based on its latest 2017Q4 regulatory filing with the SEC. 1.47 million shares were bought by Jpmorgan Chase & Company as the company’s stock declined 3.13% with the market. The institutional investor is holding 115.58M shares, compared to the 114.11M from the previous quarter. And the reported value of the health care company is $4.19 billion for the 2017Q4. $217.30B is the MC of Pfizer Inc. Ticker’s shares touched $36.53 during the last trading session after 0.11% change.Pfizer Inc. has volume of 15.78M shares. Since April 20, 2017 PFE has risen 2.43% and is uptrending. The stock underperformed the S&P500 by 9.12%.

Jpmorgan Chase & Company manages about $474.64B US Long portfolio. According to a filing the fund reduced its stake in Wabash Natl Corp (NYSE:WNC) by 409,985 shares to 3.34 million shares, valued at $72.45M in 2017Q4. For a total of 15,000 shares it reduced its holding in Cheesecake Factory Inc (Put) by 175,000 shares in the quarter, and has cut its stake in Skyworks Solutions Inc (Call).

Pfizer Inc. (NYSE:PFE) Ratings Coverage

In total 11 analysts cover Pfizer (NYSE:PFE). “Buy” rating has 5, “Sell” are 1, while 5 are “Hold”. (NYSE:PFE) has 45% bullish analysts. With $54.0 highest and $3800 lowest target, Pfizer has $41 average target or 12.24% above the current ($36.53) price. 16 are the (NYSE:PFE)’s ratings reports on 20 Apr 2018 according to StockzIntelligence Inc. On Wednesday, January 31 the stock of Pfizer Inc. (NYSE:PFE) earned “Neutral” rating by Credit Suisse. On Wednesday, January 31 the firm has “Overweight” rating given by Morgan Stanley. On Friday, December 15 the stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by BMO Capital Markets. On Tuesday, November 21 BMO Capital Markets maintained Pfizer Inc. (NYSE:PFE) with “Buy” rating. On Monday, February 26 Jefferies maintained the shares of PFE in report with “Hold” rating. On Tuesday, October 31 the stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given by Piper Jaffray. On Tuesday, January 16 the firm has “Hold” rating given by Jefferies. On Thursday, April 5 the company was downgraded by Barclays Capital. On Thursday, October 26 the rating was maintained by Jefferies with “Hold”. On Wednesday, November 1 the firm has “Buy” rating given by UBS.

Pfizer Inc. (NYSE:PFE) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.